Viewing Study NCT00028002


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-02-28 @ 6:34 PM
Study NCT ID: NCT00028002
Status: COMPLETED
Last Update Posted: 2020-10-26
First Post: 2001-12-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor
Sponsor: National Cancer Institute (NCI)
Organization: